Diaphorina citri psyllid: psy3689

Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-
MIILIDSDVTLSRVAAALLNKHLQINGITASRLDLQDTSVELEDGIMHPISDSTPNMKRERKAARTLGIIMSAFLACWLPFFIWYLGSSLCGPKCSTPRVIVVLVFWTGYFNSSLNPLIYAYFNREFRIAFKKTLQSCCYALILRRSDMEK
cEEEEEcccccHHHHHHHHHHHHccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHcccccccHHHHHccHHHHHHHHHHHHHHHcccccccccccc
MIILIDSDVTLSRVAAALLNKHLQ***************************************ARTLGIIMSAFLACWLPFFIWYLGSSLCGPKCSTPRVIVVLVFWTGYFNSSLNPLIYAYFNREFRIAFKKTLQSCCYA***RR*****
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxHHHHHHHHHHHHHHHHHHHHHHxxxxxxxxxxxxxHHHHHHHHHHHHHHHHHHHHHHHxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MIILIDSDVTLSRVAAALLNKHLQINGITASRLDLQDTSVELEDGIMHPISDSTPNMKRERKAARTLGIIMSAFLACWLPFFIWYLGSSLCGPKCSTPRVIVVLVFWTGYFNSSLNPLIYAYFNREFRIAFKKTLQSCCYALILRRSDMEK

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
5-hydroxytryptamine receptor 1A This is one of the several different receptors for 5-hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. The activity of this receptor is mediated by G proteins that inhibit adenylate cyclase activity.confidentQ9N298
5-hydroxytryptamine receptor 1A This is one of the several different receptors for 5-hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. The activity of this receptor is mediated by G proteins that inhibit adenylate cyclase activity.confidentQ64264
5-hydroxytryptamine receptor 1A This is one of the several different receptors for 5-hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. The activity of this receptor is mediated by G proteins that inhibit adenylate cyclase activity.confidentQ6XXX9

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0004989 [MF]octopamine receptor activityprobableGO:0004930, GO:0038023, GO:0060089, GO:0004888, GO:0003674, GO:0004872, GO:0004871, GO:0008227
GO:0034776 [BP]response to histamineprobableGO:0009719, GO:0050896, GO:0060359, GO:0010243, GO:0010033, GO:0008150, GO:0042221, GO:1901698, GO:0014070
GO:0035556 [BP]intracellular signal transductionprobableGO:0044700, GO:0051716, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0050789, GO:0044699
GO:0004993 [MF]serotonin receptor activityprobableGO:0004930, GO:0038023, GO:0060089, GO:0004888, GO:0003674, GO:0004872, GO:0004871, GO:0008227
GO:0008284 [BP]positive regulation of cell proliferationprobableGO:0042127, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0008283 [BP]cell proliferationprobableGO:0008150, GO:0044699
GO:0045664 [BP]regulation of neuron differentiationprobableGO:0030154, GO:0007275, GO:0044699, GO:0050767, GO:0048869, GO:0060284, GO:0050789, GO:0008150, GO:0065007, GO:0032502, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0045595, GO:0044763, GO:0051239, GO:0022008, GO:0048699, GO:0007399, GO:0044707, GO:0048856, GO:0051960, GO:2000026, GO:0048731
GO:0044428 [CC]nuclear partprobableGO:0005575, GO:0043231, GO:0005634, GO:0044464, GO:0005623, GO:0005622, GO:0044446, GO:0043229, GO:0044424, GO:0043227, GO:0043226, GO:0044422
GO:0007210 [BP]serotonin receptor signaling pathwayprobableGO:0044700, GO:0051716, GO:0008150, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007154, GO:0007186, GO:0050789, GO:0044699
GO:0035625 [BP]epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathwayprobableGO:0019220, GO:0009893, GO:0019222, GO:0033674, GO:0010647, GO:0048584, GO:0048583, GO:0042058, GO:0023056, GO:0031399, GO:0023052, GO:0007165, GO:0007166, GO:0023051, GO:1901186, GO:1901184, GO:0010646, GO:0050789, GO:0044699, GO:0080090, GO:0051716, GO:0051347, GO:0045937, GO:0048522, GO:0009966, GO:0009967, GO:0010562, GO:0043549, GO:0051246, GO:0051247, GO:0045742, GO:0043085, GO:0044093, GO:0061097, GO:0061098, GO:0065007, GO:0065009, GO:0010469, GO:0048518, GO:2000273, GO:0045859, GO:0035624, GO:0060255, GO:0031323, GO:0045741, GO:0050794, GO:0051174, GO:0007176, GO:0032268, GO:0044763, GO:0007154, GO:0010604, GO:0042325, GO:0044700, GO:0042327, GO:0001932, GO:0050790, GO:0050731, GO:0007186, GO:0050896, GO:0031401, GO:0051338, GO:0031325, GO:0050730, GO:0008150, GO:0009987, GO:0045860, GO:0001934, GO:0032270
GO:0012506 [CC]vesicle membraneprobableGO:0031090, GO:0016020, GO:0044464, GO:0005623, GO:0031988, GO:0005575, GO:0012505, GO:0043227, GO:0043226, GO:0044422, GO:0031982
GO:0007191 [BP]adenylate cyclase-activating dopamine receptor signaling pathwayprobableGO:0065007, GO:0044700, GO:0051716, GO:0008150, GO:0007212, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0050789, GO:0007188, GO:0007189, GO:0044763, GO:0007165, GO:0007166, GO:0007154, GO:0007186, GO:0007187, GO:0044699
GO:0007195 [BP]adenylate cyclase-inhibiting dopamine receptor signaling pathwayprobableGO:0044700, GO:0051716, GO:0008150, GO:0007212, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0050789, GO:0007188, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007154, GO:0007193, GO:0007186, GO:0007187, GO:0044699
GO:0007194 [BP]negative regulation of adenylate cyclase activityprobableGO:0010563, GO:0031280, GO:0080090, GO:0019222, GO:0031327, GO:0051350, GO:0031324, GO:0031323, GO:0009892, GO:1900371, GO:0045980, GO:0043086, GO:0019220, GO:0009890, GO:0030818, GO:0045761, GO:0030814, GO:0030815, GO:0050789, GO:0065007, GO:0044092, GO:0048519, GO:0065009, GO:0045934, GO:0045936, GO:0019219, GO:0050790, GO:0009889, GO:0050794, GO:0031326, GO:1900542, GO:0008150, GO:0051171, GO:0051172, GO:0030799, GO:0031279, GO:0051174, GO:1900543, GO:0030802, GO:0030809, GO:0030808, GO:1900372, GO:0030800, GO:0030803, GO:0051339, GO:0030817, GO:0006140, GO:0048523
GO:0002031 [BP]G-protein coupled receptor internalizationprobableGO:0048585, GO:0023051, GO:0048583, GO:0023057, GO:0008277, GO:0010648, GO:0022401, GO:0010646, GO:0050789, GO:0023058, GO:0009968, GO:0009966, GO:0071704, GO:0045744, GO:0065007, GO:0044699, GO:0048519, GO:0002029, GO:0009987, GO:0006810, GO:0044260, GO:0044765, GO:0008150, GO:0008152, GO:0051234, GO:0051179, GO:0050794, GO:0016192, GO:0006897, GO:0031623, GO:0006898, GO:0044237, GO:0043170, GO:0043112, GO:0048523
GO:0050482 [BP]arachidonic acid secretionprobableGO:0006869, GO:0046717, GO:0006820, GO:0015718, GO:0044699, GO:1901571, GO:0071702, GO:0033036, GO:0015909, GO:0015908, GO:0015849, GO:0006811, GO:0006810, GO:0015711, GO:0044765, GO:0008150, GO:0051234, GO:0010876, GO:0051179, GO:0046942, GO:0046903, GO:0071715, GO:0032309
GO:0042383 [CC]sarcolemmaprobableGO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886
GO:0050807 [BP]regulation of synapse organizationprobableGO:0044700, GO:0019226, GO:0032501, GO:0044707, GO:0035637, GO:0050803, GO:0050877, GO:0009987, GO:0044763, GO:0050794, GO:0051128, GO:0065007, GO:0008150, GO:0023052, GO:0007268, GO:0007267, GO:0007154, GO:0065008, GO:0050789, GO:0044699, GO:0003008
GO:0050804 [BP]regulation of synaptic transmissionprobableGO:0044057, GO:0031644, GO:0050794, GO:0065007, GO:0051239, GO:0023051, GO:0008150, GO:0051969, GO:0010646, GO:0050789
GO:0043197 [CC]dendritic spineprobableGO:0044309, GO:0044463, GO:0044464, GO:0030425, GO:0005575, GO:0097458, GO:0005623, GO:0043005, GO:0042995
GO:0032417 [BP]positive regulation of sodium:hydrogen antiporter activityprobableGO:0032414, GO:0032415, GO:0032411, GO:0032412, GO:0051049, GO:0034765, GO:0050789, GO:0043269, GO:0032409, GO:0065007, GO:0034762, GO:0044093, GO:2000649, GO:0048518, GO:0065009, GO:0002028, GO:0051050, GO:0050794, GO:0010959, GO:0008150, GO:0032879, GO:0010155, GO:0022898, GO:2000651
GO:0045935 [BP]positive regulation of nucleobase-containing compound metabolic processprobableGO:0009893, GO:0080090, GO:0019222, GO:0019219, GO:0031325, GO:0031323, GO:0050794, GO:0065007, GO:0051171, GO:0051173, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0043195 [CC]terminal boutonprobableGO:0044306, GO:0043679, GO:0044463, GO:0044464, GO:0005623, GO:0030424, GO:0005575, GO:0097458, GO:0044456, GO:0045202, GO:0043005, GO:0033267, GO:0042995
GO:0042803 [MF]protein homodimerization activityprobableGO:0046983, GO:0003674, GO:0005515, GO:0042802, GO:0005488
GO:1901386 [BP]negative regulation of voltage-gated calcium channel activityprobableGO:0032410, GO:0032412, GO:0032413, GO:0051049, GO:0034765, GO:0050789, GO:0034762, GO:0032409, GO:0065007, GO:1901020, GO:0043269, GO:0044092, GO:1901385, GO:0065009, GO:0051051, GO:0050794, GO:0010959, GO:0008150, GO:0048519, GO:0032879, GO:1901019, GO:0022898, GO:0051924, GO:2001258, GO:2001257
GO:0006260 [BP]DNA replicationprobableGO:0071704, GO:1901576, GO:0044238, GO:0008152, GO:0044260, GO:0006139, GO:0009987, GO:0006725, GO:0034641, GO:0044237, GO:0043170, GO:0090304, GO:0044249, GO:0009058, GO:0009059, GO:0006807, GO:0034645, GO:0006259, GO:0008150, GO:1901360, GO:0046483
GO:0043232 [CC]intracellular non-membrane-bounded organelleprobableGO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0043229, GO:0043228, GO:0044424, GO:0043226
GO:0004938 [MF]alpha2-adrenergic receptor activityprobableGO:0004930, GO:0004936, GO:0004935, GO:0060089, GO:0004888, GO:0003674, GO:0004872, GO:0004871, GO:0038023, GO:0008227
GO:0045597 [BP]positive regulation of cell differentiationprobableGO:0051094, GO:0050793, GO:0050794, GO:0045595, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0005887 [CC]integral to plasma membraneprobableGO:0031226, GO:0016021, GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459, GO:0031224
GO:0043203 [CC]axon hillockprobableGO:0044464, GO:0044463, GO:0044297, GO:0005623, GO:0030424, GO:0005575, GO:0097458, GO:0043005, GO:0033267, GO:0042995, GO:0043025
GO:0042321 [BP]negative regulation of circadian sleep/wake cycle, sleepprobableGO:0048585, GO:0048583, GO:0007610, GO:0042745, GO:0050789, GO:0042749, GO:0051241, GO:0048511, GO:0048512, GO:0065007, GO:0048519, GO:0007623, GO:0007622, GO:0050795, GO:0042752, GO:0045187, GO:0008150, GO:0022410, GO:0051239, GO:0044708, GO:0050896, GO:0042754, GO:0048521
GO:0008144 [MF]drug bindingprobableGO:0003674, GO:0005488
GO:0044767 [BP]single-organism developmental processprobableGO:0032502, GO:0008150, GO:0044699
GO:1901700 [BP]response to oxygen-containing compoundprobableGO:0042221, GO:0050896, GO:0008150
GO:0051378 [MF]serotonin bindingprobableGO:0043169, GO:0097159, GO:0043167, GO:0003674, GO:0005488, GO:0043176, GO:1901363
GO:0051379 [MF]epinephrine bindingprobableGO:1901338, GO:0003674, GO:0005488, GO:0097159
GO:0032148 [BP]activation of protein kinase B activityprobableGO:0019220, GO:0009893, GO:0019222, GO:0033674, GO:0031325, GO:0031323, GO:0032147, GO:0045860, GO:0050789, GO:0043085, GO:0080090, GO:0051347, GO:0010604, GO:0010562, GO:0043549, GO:0051246, GO:0051247, GO:0032270, GO:0044093, GO:0031399, GO:0048518, GO:0065007, GO:0065009, GO:0050790, GO:0045937, GO:0060255, GO:0045859, GO:0050794, GO:0051174, GO:0008150, GO:0042325, GO:0042327, GO:0032268, GO:0031401, GO:0051338, GO:0001932, GO:0001934, GO:0048522
GO:0016023 [CC]cytoplasmic membrane-bounded vesicleprobableGO:0005737, GO:0031982, GO:0031410, GO:0044464, GO:0044444, GO:0005623, GO:0031988, GO:0005575, GO:0043229, GO:0044424, GO:0005622, GO:0043227, GO:0043226, GO:0043231
GO:0035240 [MF]dopamine bindingprobableGO:0043169, GO:0097159, GO:0043167, GO:0003674, GO:0005488, GO:1901338
GO:0031328 [BP]positive regulation of cellular biosynthetic processprobableGO:0009893, GO:0019222, GO:0009891, GO:0031326, GO:0031325, GO:0009889, GO:0050794, GO:0031323, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0050709 [BP]negative regulation of protein secretionprobableGO:0070201, GO:0032879, GO:0050708, GO:0051046, GO:0051051, GO:0051048, GO:0051049, GO:0060341, GO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:0051223, GO:0051224, GO:0050789, GO:0048523, GO:0032880
GO:0009605 [BP]response to external stimulusprobableGO:0050896, GO:0008150
GO:0071883 [BP]activation of MAPK activity by adrenergic receptor signaling pathwayprobableGO:0000187, GO:0019220, GO:0009893, GO:0019222, GO:0033674, GO:0031325, GO:0048584, GO:0048583, GO:0032147, GO:0023056, GO:0043406, GO:0043405, GO:0023052, GO:0007165, GO:0007166, GO:0023051, GO:0071902, GO:0010647, GO:0071900, GO:0010627, GO:0050789, GO:0044699, GO:0043408, GO:0051716, GO:0010646, GO:0051347, GO:0010604, GO:0009966, GO:0009967, GO:0010562, GO:0043549, GO:0051246, GO:0051247, GO:0032270, GO:0043085, GO:0044093, GO:0031399, GO:0048518, GO:0065007, GO:0051174, GO:0010740, GO:0050790, GO:0045937, GO:0060255, GO:0031323, GO:0045859, GO:0080090, GO:0050794, GO:0043410, GO:0071875, GO:0032268, GO:0044763, GO:0007154, GO:0065009, GO:0042325, GO:0044700, GO:0042327, GO:0001932, GO:0007186, GO:0050896, GO:0031401, GO:0051338, GO:0008150, GO:0009987, GO:0045860, GO:0001934, GO:0048522
GO:0017124 [MF]SH3 domain bindingprobableGO:0003674, GO:0019904, GO:0005515, GO:0005488
GO:0007615 [BP]anesthesia-resistant memoryprobableGO:0032501, GO:0044707, GO:0044708, GO:0050896, GO:0050890, GO:0007613, GO:0007610, GO:0007611, GO:0008150, GO:0050877, GO:0044699, GO:0003008
GO:0043270 [BP]positive regulation of ion transportprobableGO:0051050, GO:0051049, GO:0065007, GO:0048518, GO:0008150, GO:0032879, GO:0050789, GO:0043269
GO:0060406 [BP]positive regulation of penile erectionprobableGO:0060405, GO:2000243, GO:0051240, GO:2000241, GO:0043900, GO:0065007, GO:0051239, GO:0048518, GO:0008150, GO:0050789
GO:0097114 [BP]N-methyl-D-aspartate receptor clusteringprobableGO:0050808, GO:0061024, GO:0008104, GO:0007275, GO:0044699, GO:0070727, GO:0001941, GO:0071840, GO:0016043, GO:0007416, GO:0051641, GO:0032502, GO:0034613, GO:0022607, GO:0032501, GO:0009987, GO:0008150, GO:0072657, GO:0048731, GO:0051179, GO:0048856, GO:0033036, GO:0044707, GO:0007399, GO:0072578, GO:0044085, GO:0016044, GO:0044763, GO:0043113
GO:0004952 [MF]dopamine neurotransmitter receptor activityprobableGO:0004930, GO:0030594, GO:0038023, GO:0060089, GO:0004888, GO:0003674, GO:0004872, GO:0004871
GO:0006950 [BP]response to stressprobableGO:0050896, GO:0008150
GO:0005938 [CC]cell cortexprobableGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0071944, GO:0044424
GO:0071310 [BP]cellular response to organic substanceprobableGO:0051716, GO:0050896, GO:0009987, GO:0008150, GO:0044763, GO:0070887, GO:0042221, GO:0010033, GO:0044699
GO:0051482 [BP]elevation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathwayprobableGO:0050801, GO:0042592, GO:0023052, GO:0007165, GO:0007166, GO:0050789, GO:0044699, GO:0072507, GO:0051716, GO:0072503, GO:0065007, GO:0065008, GO:0007186, GO:0019725, GO:0006875, GO:0006874, GO:0009987, GO:0006873, GO:0050794, GO:0044763, GO:0030003, GO:0055065, GO:0055080, GO:0007154, GO:0055082, GO:0044700, GO:0051480, GO:0007200, GO:0050896, GO:0007204, GO:0048878, GO:0008150, GO:0055074
GO:0031117 [BP]positive regulation of microtubule depolymerizationprobableGO:0031110, GO:0051130, GO:0031112, GO:0031114, GO:0033043, GO:0051493, GO:0051495, GO:1901879, GO:0010638, GO:1901881, GO:0051128, GO:0008150, GO:0065007, GO:0050794, GO:0032886, GO:0048518, GO:0043244, GO:0070507, GO:0050789, GO:0043243, GO:0048522
GO:0060259 [BP]regulation of feeding behaviorprobableGO:0008150, GO:0065007, GO:0048583, GO:0050789, GO:0050795

Prediction of Enzyme Commission Number ?

No EC number assigned to the protein, probably not an enzyme!

Spatial Structural Prediction

Structural Models Based on Templates

Template: 3RZE, chain A
Confidence level:very confident
Coverage over the Query: 56-137
View the alignment between query and template
View the model in PyMOL
Template: 2R4R, chain A
Confidence level:probable
Coverage over the Query: 21-35,56-83,105-150
View the alignment between query and template
View the model in PyMOL